AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Elglib M 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Suraksha Pharma Pvt Ltd

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Elglib M 5mg/500mg Tablet

Metformin/Glimepiride 5mg/500mg tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and carry a fast-acting glucose source, such as candy or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Elglib M 5mg/500mg Tablet

No text provided to rephrase.

Uses of Elglib M 5mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Elglib M 5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Elglib M 5mg/500mg Tablet should be administered with a meal.

Common Side effects of Elglib M 5mg/500mg Tablet:

  • Dizziness
  • Diarrhea
  • Nausea
  • Flatulence
  • Headache
  • Upper respiratory tract infection

How to use Elglib M 5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. It's recommended to take Elglib M 5mg/500mg Tablet with a meal.

How Elglib M 5mg/500mg Tablet works:

Glibenclamide, a sulfonylurea agent, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide drug, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Elglib M 5mg/500mg tablets with alcohol is not advisable.

PregnancyPregnancySAFE IF PRESCRIBED

Use of Elglib M 5mg/500mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Mothers who are breastfeeding should exercise caution when taking Elglib M 5mg/500mg tablets. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while taking Elglib M 5mg/500mg Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Elglib M 5mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Elglib M 5mg/500mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

What if you forget to take Elglib M 5mg/500mg Tablet :

Should you forget to take your Elglib M 5mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Elglib M 5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Elglib M 5mg/500mg Tablet

Elglib M 5mg/500mg tablets combine glibenclamide and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, arises from the body's inability to produce sufficient insulin or utilize existing insulin effectively. This results in elevated blood glucose, causing various health issues. Symptoms include excessive urination, thirst, and hunger. Untreated, type 2 diabetes can lead to long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and increased risk of heart disease.
Elglib M 5mg/500mg tablets may cause common side effects such as hypoglycemia, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Elglib M 5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Prolonged use of Elglib M 5mg/500mg Tablet can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplementation with Vitamin B12 is recommended by some researchers.
Elglib M 5mg/500mg Tablet is contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with metabolic acidosis, including diabetic ketoacidosis.
Combining Elglib M 5mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Elglib M 5mg/500mg tablets combine glibenclamide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, arises from the body's inability to produce sufficient insulin or utilize existing insulin effectively. This leads to elevated blood glucose, causing serious health issues. High blood sugar symptoms include excessive urination, thirst, and hunger. Untreated, type 2 diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and an increased risk of heart disease.
Elglib M 5mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Elglib M 5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged use of Elglib M 5mg/500mg Tablets can interfere with vitamin B12 absorption, leading to deficiency. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Elglib M 5mg/500mg Tablets are contraindicated in patients with allergies to any ingredient, those with moderate to severe kidney disease, and those with metabolic acidosis, including diabetic ketoacidosis.
Combining Elglib M 5mg/500mg tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Elglib M 5mg/500mg Tablet
96
MRP 111
13% off